Clinical trials in ventilator treatment: current perspectives and future challenges

Area of Science:

• Critical care medicine
• Clinical trial design
• Respiratory support

Background:

• Mortality/morbidity end points are effective for treatments with large effect sizes.
• Ventilation, as a supportive measure, acts as a moderator variable with a modest impact on mortality.
• Over-reliance on final outcomes may lead to discarding potentially useful innovations in respiratory support.

Purpose of the Study:

• To highlight the limitations of traditional outcome-based end points in evaluating ventilation strategies.
• To emphasize the importance of considering 'moderator variables' in clinical trial design.
• To advocate for a more dynamic approach in assessing new ventilation developments.

Main Methods:

• Discussion of the impact of effect size on sample size requirements.
• Analysis of limitations in recruiting large, heterogeneous patient populations for prolonged trials.
• Exploration of nonlinear interactions in critical illness and their effect on outcomes.

Main Results:

• Modest effect sizes necessitate large sample sizes, posing recruitment and logistical challenges.
• Heterogeneity in patient populations and evolving clinical practices complicate long-term studies.
• Nonlinear interactions in critical illness can lead to unpredictable outcomes and potentially erroneous conclusions in trials involving moderator variables.

Conclusions:

• Traditional outcome-based end points are insufficient for evaluating interventions like ventilation.
• A dynamic evaluation approach is crucial for designing future clinical trials on ventilation strategies.
• Careful consideration of moderator variables and nonlinear dynamics is essential for accurate assessment of new treatments.